Tragara Pharmaceuticals Chief Executive Officer, Thomas M. Estok, to speak at Defined Health's annual pharma conference, Therapeutic Insight, taking place in New York City March 31st through April 2nd, 2009.

Mr. Estok will be a participant on the panel “The Next Oncology Blockbusters – Innovation Drift or Paradigm Shift?” Also participating on the panel will be Steve Hoerter, Sr. Director, BioOncology Marketing and Pipeline Commercial Development, Genentech; Eric Rowinsky, MD, EVP & Chief Medical Officer, Imclone; and Mark Edwards, Principal, Deloitte Recap LLC.

The panel discussion will occur April 2nd at 2:45 pm and will be moderated by Jeffrey M. Bockman, PhD, VP of Defined Health.

The event will take place July 22nd, 2009 from 5:00p - 7:00p.